Pro Medicus Limited (ASX:PME)
176.42
-2.97 (-1.66%)
Sep 1, 2026, 4:10 PM AEST
Pro Medicus Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 261.69 | 212.98 | 161.5 | 124.9 | 93.46 |
| 261.69 | 212.98 | 161.5 | 124.9 | 93.46 | |
Revenue Growth | 22.87% | 31.87% | 29.30% | 33.64% | 37.31% |
Cost of Revenue | 0.4 | 0.31 | 0.3 | 0.54 | 0.47 |
Gross Profit | 261.29 | 212.67 | 161.2 | 124.36 | 93 |
Selling, General & Admin | 53.78 | 47.04 | 38.7 | 31.07 | 21.56 |
Other Operating Expenses | 3.33 | 0.7 | 1.74 | 1.29 | 2.8 |
Operating Expenses | 65.17 | 54.98 | 48.95 | 40.28 | 31.68 |
Operating Income | 196.12 | 157.69 | 112.25 | 84.08 | 61.31 |
Interest & Investment Income | 9.06 | 7.56 | 4.83 | 2.43 | 0.65 |
Currency Exchange Gain (Loss) | -1.9 | -2.03 | -1.12 | -0.39 | 1.12 |
Other Non Operating Income (Expenses) | - | - | 0.54 | 0 | - |
EBT Excluding Unusual Items | 203.28 | 163.21 | 116.5 | 86.13 | 63.08 |
Gain (Loss) on Sale of Investments | 174.24 | 0.1 | - | - | - |
Pretax Income | 377.52 | 163.31 | 116.5 | 86.13 | 63.08 |
Income Tax Expense | 112.17 | 48.1 | 33.7 | 25.48 | 18.64 |
Net Income | 265.34 | 115.22 | 82.79 | 60.65 | 44.44 |
Net Income to Common | 265.34 | 115.22 | 82.79 | 60.65 | 44.44 |
Net Income Growth | 130.30% | 39.16% | 36.52% | 36.47% | 44.06% |
Shares Outstanding (Basic) | 104 | 104 | 104 | 104 | 104 |
Shares Outstanding (Diluted) | 105 | 105 | 105 | 105 | 105 |
Shares Change | -0.01% | 0.01% | 0.06% | 0.01% | -0.01% |
EPS (Basic) | 2.54 | 1.10 | 0.79 | 0.58 | 0.43 |
EPS (Diluted) | 2.54 | 1.10 | 0.79 | 0.58 | 0.42 |
EPS Growth | 130.34% | 39.19% | 36.38% | 36.47% | 44.07% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 127.04 | 110.89 | 81.67 | 62.24 | 61.34 |
Free Cash Flow Per Share | 1.21 | 1.06 | 0.78 | 0.59 | 0.59 |
Dividend Per Share | 0.690 | 0.550 | 0.400 | 0.300 | 0.220 |
Dividend Growth | 25.45% | 37.50% | 33.33% | 36.36% | 46.67% |
Gross Margin | 99.85% | 99.86% | 99.81% | 99.56% | 99.50% |
Operating Margin | 74.94% | 74.04% | 69.50% | 67.32% | 65.60% |
Profit Margin | 101.40% | 54.10% | 51.27% | 48.56% | 47.55% |
Free Cash Flow Margin | 48.55% | 52.07% | 50.57% | 49.83% | 65.63% |
EBITDA | 196.49 | 158.02 | 112.52 | 84.37 | 61.59 |
EBITDA Margin | 75.08% | 74.19% | 69.67% | 67.55% | 65.89% |
D&A For EBITDA | 0.37 | 0.33 | 0.27 | 0.29 | 0.27 |
EBIT | 196.12 | 157.69 | 112.25 | 84.08 | 61.31 |
EBIT Margin | 74.94% | 74.04% | 69.50% | 67.32% | 65.60% |
Effective Tax Rate | 29.71% | 29.45% | 28.93% | 29.58% | 29.54% |
Revenue as Reported | 270.75 | 220.54 | 166.33 | 127.33 | 94.11 |
Advertising Expenses | 3.92 | 3.74 | 2.89 | 2.52 | 1.95 |